Coronary CTA for Radiation Therapy Planning in Lymphoma Patients
About this study
Our purpose for this study is to help design a therapy plan that can decrease extra radiation exposure to your heart during radiotherapy. The therapy plan will use images obtained using a dual-source CT scanner
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
Patients between 7 and 65 years of age with a confirmed diagnosis of Hodgkin or non-Hodgkin lymphoma involving the mediastinum who are scheduled for radiotherapy
Written informed consent signed.For pediatric patients, the consent form has to be signed by parent or guardian
Is not pregnant for female patients of childbearing age
- Severe renal insufficiency, defined as a serum creatinine >1.9 mg/dL
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.
|Mayo Clinic Location
Mayo Clinic principal investigator
Eric Williamson, M.D.
Open for enrollment
Eric Williamson M.D.